1. Helicobacter pylori management in ASEAN: The Bangkok consensus report.
- Author
-
Mahachai V, Vilaichone RK, Pittayanon R, Rojborwonwitaya J, Leelakusolvong S, Maneerattanaporn M, Chotivitayatarakorn P, Treeprasertsuk S, Kositchaiwat C, Pisespongsa P, Mairiang P, Rani A, Leow A, Mya SM, Lee YC, Vannarath S, Rasachak B, Chakravuth O, Aung MM, Ang TL, Sollano JD, Trong Quach D, Sansak I, Wiwattanachang O, Harnsomburana P, Syam AF, Yamaoka Y, Fock KM, Goh KL, Sugano K, and Graham D
- Subjects
- Amoxicillin administration & dosage, Anti-Bacterial Agents administration & dosage, Bismuth administration & dosage, Clarithromycin administration & dosage, Drug Resistance, Bacterial, Drug Therapy, Combination, Fluoroquinolones administration & dosage, Follow-Up Studies, Gastritis diagnosis, Humans, Japan, Metronidazole administration & dosage, Proton Pump Inhibitors administration & dosage, Taiwan, Tetracycline administration & dosage, Thailand, Treatment Outcome, United States, Consensus, Gastritis drug therapy, Gastritis epidemiology, Gastritis microbiology, Helicobacter Infections, Helicobacter pylori
- Abstract
Helicobacter pylori (H. pylori) infection remains to be the major cause of important upper gastrointestinal diseases such as chronic gastritis, peptic ulcer, gastric adenocarcinoma, and mucosa-associated lymphoid tissue lymphoma. H. pylori management in ASEAN: the Bangkok consensus report gathered key opinion leaders for the region to review and evaluate clinical aspects of H. pylori infection and to develop consensus statements, rationales, and grades of recommendation for the management of H. pylori infection in clinical practice in ASEAN countries. This ASEAN Consensus consisted of 34 international experts from 10 ASEAN countries, Japan, Taiwan, and the United States. The meeting mainly focused on four issues: (i) epidemiology and disease association; (ii) diagnostic tests; (iii) management; and (iv) follow-up after eradication. The final results of each workshop were presented for consensus voting by all participants. Statements, rationale, and recommendations were developed from the available current evidence to help clinicians in the diagnosis and treatment of H. pylori and its clinical diseases., (© 2017 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.)
- Published
- 2018
- Full Text
- View/download PDF